Abida Raza
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Drug Discovery top 2%
Papers in
- Hepatology 25
- Hepatitis C virus research 24
-
- RNA Interference and Gene Delivery 7
- Co-authors
- Muhammad Ovais (16 shared papers)Zabta Khan Shinwari (9 shared papers)Ali Talha Khalil (8 shared papers)Irshad Ahmad (7 shared papers)Nazar Ul Islam (4 shared papers)Muhammad Ayaz (4 shared papers)Muhammad Ali (4 shared papers)Muhammad Adeeb Khan (4 shared papers)
- Journals
- International Journal of Infectious Diseases (5 papers)Nanomedicine (5 papers)Current Pharmaceutical Biotechnology (3 papers)IET Nanobiotechnology (3 papers)Applied Microbiology and Biotechnology (3 papers)
- Partner nations
- PakistanSaudi ArabiaUnited States
In The Last Decade
Abida Raza
85 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 130
- Biomaterials 501
- Drug Discovery 5
- Complementary and alternative medicine 215
- Hepatology 187
- Pharmaceutical Science 145
Countries citing papers authored by Abida Raza
This map shows the geographic impact of Abida Raza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abida Raza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abida Raza more than expected).
Fields of papers citing papers by Abida Raza
This network shows the impact of papers produced by Abida Raza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abida Raza. The network helps show where Abida Raza may publish in the future.
Co-authors
The 25 scholars most cited alongside Abida Raza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 309 | |
| 2 | 2020 | 184 | |
| 3 | 2018 | 143 | |
| 4 | 2017 | 129 | |
| 5 | 2018 | 126 | |
| 6 | 2017 | 122 | |
| 7 | 2017 | 122 | |
| 8 | 2018 | 119 | |
| 9 | 2018 | 113 | |
| 10 | 1994 | 101 | |
| 11 | 2016 | 76 | |
| 12 | 2016 | 66 | |
| 13 | 2022 | 65 | |
| 14 | 2001 | 62 | |
| 15 | 2017 | 59 | |
| 16 | 2017 | 51 | |
| 17 | 2001 | 50 | |
| 18 | 2018 | 48 | |
| 19 | 1990 | 45 | |
| 20 | 2002 | 39 |
About Abida Raza
Abida Raza is a scholar working on Hepatology, Molecular Biology, Biomaterials, Epidemiology and Materials Chemistry, having authored 89 papers that have together received 2.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (24 papers), Nanoparticle-Based Drug Delivery (21 papers), Nanoparticles: synthesis and applications (12 papers), Hepatitis B Virus Studies (11 papers), Liver Disease Diagnosis and Treatment (10 papers), Nanoplatforms for cancer theranostics (9 papers), RNA Interference and Gene Delivery (7 papers) and Advanced Drug Delivery Systems (4 papers). The work is most often cited by research in Biomaterials (501 citations), Drug Discovery (5 citations), Complementary and alternative medicine (215 citations), Hepatology (187 citations) and Pharmaceutical Science (145 citations). Abida Raza has collaborated with scholars based in Pakistan, Saudi Arabia and United States. Frequent co-authors include Muhammad Ovais, Zabta Khan Shinwari, Ali Talha Khalil, Irshad Ahmad, Nazar Ul Islam, Muhammad Ayaz, Muhammad Ali, Muhammad Adeeb Khan, Muthupandian Saravanan and Sudip Mukherjee. Their work appears in journals such as International Journal of Infectious Diseases, Nanomedicine, Current Pharmaceutical Biotechnology, IET Nanobiotechnology and Applied Microbiology and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.